WallStreetZenWallStreetZen

NASDAQ: BPTH
Bio Path Holdings Inc Stock

$0.44+0.00 (+0%)
Updated Feb 21, 2024
BPTH Price
$0.44
Fair Value Price
N/A
Market Cap
$5.47M
52 Week Low
$0.32
52 Week High
$2.24
P/E
-0.22x
P/B
2.17x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$16.67M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.99
Operating Cash Flow
-$15M
Beta
0.65
Next Earnings
Mar 29, 2024
Ex-Dividend
N/A
Next Dividend
N/A

BPTH Overview

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nano particle drug development company in the United States. The company develops products based on DNAbilize, a drug delivery and antisense technology that uses P-ethoxy, which is a deoxyribonucleic acid (DNA) backbone modification intended to protect the DNA from destruction. Its lead drug candidate is prexigebersen, which is in Phase II clinical trials for the treatment of acute myeloid leukemia (AML) and myelodysplastic syndrome. It is also developing Liposomal Bcl-2 for the treatment of refractory/relapsed lymphoma and chronic lymphocytic leukemia; Liposomal STAT3 that is in preclinical stage for the treatment of pancreatic cancer, non-small cell lung cancer, and AML; and prexigebersen-A for various solid tumors. Bio-Path Holdings, Inc. was founded in 2007 and is based in Bellaire, Texas.

Zen Score

Industry Average (22)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BPTH scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BPTH is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BPTH is good value based on its book value relative to its share price (2.17x), compared to the US Biotechnology industry average (5.97x)
P/B vs Industry Valuation
BPTH is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more BPTH due diligence checks available for Premium users.

Be the first to know about important BPTH news, forecast changes, insider trades & much more!

BPTH News

Valuation

BPTH fair value

Fair Value of BPTH stock based on Discounted Cash Flow (DCF)
Price
$0.44
Fair Value
$1.40
Undervalued by
68.50%
BPTH is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

BPTH price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-0.22x
Industry
16.04x
Market
28.8x

BPTH price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
2.17x
Industry
5.97x
BPTH is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BPTH's financial health

Profit margin

Revenue
$0.0
Net Income
-$3.2M
Profit Margin
0%
BPTH's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$5.0M
Liabilities
$2.5M
Debt to equity
0.99
BPTH's short-term assets ($4.80M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
BPTH's short-term assets ($4.80M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
BPTH's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
BPTH's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$2.8M
Investing
$0.0
Financing
$0.0
BPTH's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

BPTH vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
BPTH$5.47M+1.61%-0.22x2.17x
SNPX$5.42M+31.03%-0.25x0.20x
GTBP$5.58M-8.80%-0.45x0.56x
MYMD$5.63M-11.23%-0.61x0.36x
TCON$5.64M-2.69%-0.31x-1.83x

Bio Path Holdings Stock FAQ

What is Bio Path Holdings's quote symbol?

(NASDAQ: BPTH) Bio Path Holdings trades on the NASDAQ under the ticker symbol BPTH. Bio Path Holdings stock quotes can also be displayed as NASDAQ: BPTH.

If you're new to stock investing, here's how to buy Bio Path Holdings stock.

What is the 52 week high and low for Bio Path Holdings (NASDAQ: BPTH)?

(NASDAQ: BPTH) Bio Path Holdings's 52-week high was $2.24, and its 52-week low was $0.32. It is currently -80.22% from its 52-week high and 38.44% from its 52-week low.

How much is Bio Path Holdings stock worth today?

(NASDAQ: BPTH) Bio Path Holdings currently has 12,352,664 outstanding shares. With Bio Path Holdings stock trading at $0.44 per share, the total value of Bio Path Holdings stock (market capitalization) is $5.47M.

Bio Path Holdings stock was originally listed at a price of $180.00 in Mar 4, 2008. If you had invested in Bio Path Holdings stock at $180.00, your return over the last 15 years would have been -99.75%, for an annualized return of -33% (not including any dividends or dividend reinvestments).

How much is Bio Path Holdings's stock price per share?

(NASDAQ: BPTH) Bio Path Holdings stock price per share is $0.44 today (as of Feb 21, 2024).

What is Bio Path Holdings's Market Cap?

(NASDAQ: BPTH) Bio Path Holdings's market cap is $5.47M, as of Feb 22, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Bio Path Holdings's market cap is calculated by multiplying BPTH's current stock price of $0.44 by BPTH's total outstanding shares of 12,352,664.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.